BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37159454)

  • 1. Mechanisms underlying the antiarrhythmic effect of ARumenamide-787 in experimental models of the J wave syndromes and hypothermia.
    Di Diego JM; Barajas-Martinez H; Cox R; Robinson VM; Jung J; Fouda M; Patocskai B; Abdelsayed M; Ruben PC; Antzelevitch C
    PLoS One; 2023; 18(5):e0281977. PubMed ID: 37159454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acacetin suppresses the electrocardiographic and arrhythmic manifestations of the J wave syndromes.
    Di Diego JM; Patocskai B; Barajas-Martinez H; Borbáth V; Ackerman MJ; Burashnikov A; Clatot J; Li GR; Robinson VM; Hu D; Antzelevitch C
    PLoS One; 2020; 15(11):e0242747. PubMed ID: 33232375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome.
    Koncz I; Gurabi Z; Patocskai B; Panama BK; Szél T; Hu D; Barajas-Martínez H; Antzelevitch C
    J Mol Cell Cardiol; 2014 Mar; 68():20-8. PubMed ID: 24378566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome.
    Patocskai B; Yoon N; Antzelevitch C
    JACC Clin Electrophysiol; 2017 Apr; 3(4):353-363. PubMed ID: 28948234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome.
    Szél T; Koncz I; Antzelevitch C
    Heart Rhythm; 2013 Nov; 10(11):1720-7. PubMed ID: 23911896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone.
    Gurabi Z; Koncz I; Patocskai B; Nesterenko VV; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):134-42. PubMed ID: 24429494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
    Patocskai B; Barajas-Martinez H; Hu D; Gurabi Z; Koncz I; Antzelevitch C
    Heart Rhythm; 2016 Jun; 13(6):1326-34. PubMed ID: 26820510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.
    Minoura Y; Di Diego JM; Barajas-Martínez H; Zygmunt AC; Hu D; Sicouri S; Antzelevitch C
    J Cardiovasc Electrophysiol; 2012 Apr; 23(4):423-32. PubMed ID: 22034916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic Effect of Artemisinin in an Ex-vivo Model of Brugada Syndrome Induced by NS5806.
    Jeong HK; Hong SN; Yoon N; Lee KH; Park HW; Cho JG
    Korean Circ J; 2023 Apr; 53(4):239-250. PubMed ID: 37161682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome.
    Calloe K; Cordeiro JM; Di Diego JM; Hansen RS; Grunnet M; Olesen SP; Antzelevitch C
    Cardiovasc Res; 2009 Mar; 81(4):686-94. PubMed ID: 19073629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicardial Substrate as a Target for Radiofrequency Ablation in an Experimental Model of Early Repolarization Syndrome.
    Yoon N; Patocskai B; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2018 Sep; 11(9):e006511. PubMed ID: 30354293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous activation of the small conductance calcium-activated potassium current by acetylcholine and inhibition of sodium current by ajmaline cause J-wave syndrome in Langendorff-perfused rabbit ventricles.
    Fei YD; Chen M; Guo S; Ueoka A; Chen Z; Rubart-von der Lohe M; Everett TH; Qu Z; Weiss JN; Chen PS
    Heart Rhythm; 2021 Jan; 18(1):98-108. PubMed ID: 32763429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sophoridine manifests as a leading compound for anti-arrhythmia with multiple ion-channel blocking effects.
    Song T; Hao Y; Wang M; Li T; Zhao C; Li J; Hou Y
    Phytomedicine; 2023 Apr; 112():154688. PubMed ID: 36738478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome.
    Minoura Y; Panama BK; Nesterenko VV; Betzenhauser M; Barajas-Martínez H; Hu D; Di Diego JM; Antzelevitch C
    Heart Rhythm; 2013 Jul; 10(7):1054-62. PubMed ID: 23499631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis of patients withJ-wave syndrome.
    Kamakura T; Shinohara T; Yodogawa K; Murakoshi N; Morita H; Takahashi N; Inden Y; Shimizu W; Nogami A; Horie M; Aiba T; Kusano K
    Heart; 2020 Feb; 106(4):299-306. PubMed ID: 31391205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naringin exerts antiarrhythmic effects by inhibiting channel currents in mouse cardiomyocytes.
    Li SH; Ma GL; Zhang SL; Yang YY; Liu HF; Luo A; Wen J; Cao ZZ; Jia YZ
    J Electrocardiol; 2023; 80():69-80. PubMed ID: 37262953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.
    Zhang ZH; Barajas-Martínez H; Xia H; Li B; Capra JA; Clatot J; Chen GX; Chen X; Yang B; Jiang H; Tse G; Aizawa Y; Gollob MH; Scheinman M; Antzelevitch C; Hu D
    J Am Coll Cardiol; 2021 Oct; 78(16):1603-1617. PubMed ID: 34649698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. J wave syndromes: molecular and cellular mechanisms.
    Antzelevitch C
    J Electrocardiol; 2013; 46(6):510-8. PubMed ID: 24011992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.
    Yan GX; Antzelevitch C
    Circulation; 1999 Oct; 100(15):1660-6. PubMed ID: 10517739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A carvedilol analogue, VK-II-86, prevents hypokalaemia-induced ventricular arrhythmia through novel multi-channel effects.
    Robinson VM; Alsalahat I; Freeman S; Antzelevitch C; Barajas-Martinez H; Venetucci L
    Br J Pharmacol; 2022 Jun; 179(11):2713-2732. PubMed ID: 34877651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.